Channels - Cenobamate: An Appraisal Five Years On :: FRELIP Discovery

Similar Items: Cenobamate: An Appraisal Five Years On

Quick Look
Hypersensitivity reaction risk when restarting cenobamate after discontinuation: Insights from a prolonged hospitalized cohort
Quick Look
Effectiveness of adjunctive low‐dose clobazam in adults with focal drug‐resistant epilepsy and incomplete response to cenobamate: A real‐world study
Quick Look
Multidisciplinary Treatment for Conversion Disorder in an 8 Year Old Girl
Quick Look
Risk for ASD in Preterm Infants: A Three-Year Follow-Up Study
Quick Look
Pediatric Radiologically Isolated Syndrome (RIS): A Case with Active Disease 18 Years Later
Quick Look
Evaluating the Clinical Utility of the Interpersonal Hopelessness Scale Among Adults With Past‐Year Suicide Ideation
Quick Look
Correction to: Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years
Quick Look
Successful Clozapine Rechallenge in a 40-Year-Old Male Patient With Paranoid Schizophrenia After Clozapine-Associated Myocarditis
Quick Look
Autism and Its Lookalikes: A Case Report of a Child Whose Autism Diagnosis No Longer Fit Years Later
Quick Look
Long-Term Effectiveness and Safety of LCIG in Romania. 3-year Results from a Prospective, Observational Study (DUOGLOBE)
Quick Look
Assessment, Intervention, Monitoring, Step‐Up/Step‐Down (AIMS) in Action: 5 Years Review of Transforming Transitions in Crisis Care
Quick Look
When Delusion Becomes Reality: A Six-Year Diagnostic Odyssey and Ethical Crisis in a Case of Veridical Spousal Infidelity Belief
Quick Look
A 24-Year-Old Male Adult With a Severe Intellectual Developmental Disorder and Intractable Challenging Behaviors: A Case Report
Quick Look
A clustering based on the dynamics of DSM-5 criteria for gambling disorder: A 5-year follow-up of gamblers with and without gambling disorder
Quick Look
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study
Quick Look
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program
Quick Look
Clozapine as an Off-Label Treatment for Severe and Treatment-Resistant (Auto-)Aggressive Behavior in a 40-Year-Old Patient With Mild Intellecutal Disability and Borderline Personality Disorder
Quick Look
Psychometric Properties and Longitudinal Predictors of the Columbia Suicide Severity Rating Scale (C‐SSRS) in a Brazilian Community Cohort: A 15‐Year Follow‐Up Study
Quick Look
Differential Effects of High and Low Frequency Subthalamic Nucleus Deep Brain Stimulation on Force Steadiness in Patients with Parkinson’s Disease: An Exploratory Study
Quick Look
Using Virtual Reality to Complement Paper-and-Pencil Tests to Assess Visual Unilateral Spatial Neglect: A Feasibility Study
Quick Look
Mitigating the Impact of MR Sequence Parameters: Increasing the Robustness of DL‐Based Cortical Thickness Estimates
Quick Look
The Effectiveness of a Structured Educational Intervention on Knowledge, Beliefs, and Self‐Reported Practices of Pregnant Women Exposed to Thirdhand Smoke: A Randomized Controlled Trial
Quick Look
Alcohol Cues Elicit Differences in Brain Activation Patterns of Abstinent Men and Women with Alcohol Use Disorders
Quick Look
Integrating Molecular Pathology, Tumor Microenvironment, and Novel Therapies to Overcome Resistance in Glioblastoma